FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe

Siobhan O'Brien, Tajinder Ubhi, Lucie Wolf, Krishna Gandhi, Sichun Lin, Naz Chaudary, Neesha C. Dhani, Michael Milosevic, Grant W. Brown, Stephane Angers · 2023

Read FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe by Siobhan O'Brien, Tajinder Ubhi, Lucie Wolf, Krishna Gandhi, Sichun Lin, Naz Chaudary, Neesha C. Dhani, Michael Milosevic, Grant W. Brown, Stephane Angers (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10734389.txt.

Description

Siobhan O'Brien and co-authors find a drug weakness in cancers that have lost the tumor suppressor FBXW7. Their 2023 paper begins with genome-wide CRISPR screens, which flagged DNA repair genes as essential in cells lacking FBXW7. Such mutant cells live with high replication stress, damage that builds as they copy their DNA.

Because of that stress, the mutant cells lean hard on the ATR checkpoint pathway to survive. Blocking ATR pushed them into a rushed cell division that ended in mitotic catastrophe and death. The effect held across cell and organoid models and matched patterns in large drug screening datasets. The authors propose ATR inhibitors as targeted therapy for FBXW7-mutant cancers. The work also shows how gene screens can point straight to a drug strategy.

Catalog record

CREATORSiobhan O'Brien, Tajinder Ubhi, Lucie Wolf, Krishna Gandhi, Sichun Lin, Naz Chaudary, Neesha C. Dhani, Michael Milosevic, Grant W. Brown, Stephane Angers
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10734389

Browse the full library · About the Tower of Babel